Gilead Sciences (NASDAQ: GILD) Uptrend is Almost Scary, but It's Not Over Yet

Gilead Sciences (NASDAQ: GILD) is a closely followed stock in the biotechnology industry. It is currently the top holding in the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB), comprising 7.83% of the ETF's assets.
On Thursday, IBB closed at a fresh all-time high, making three new closing highs three days in a row. With such great momentum behind the sector ETF, GILD looks poised to break past its near-term layer of resistance and participate in this rally in a more meaningful way.
On Feb. 4, Gilead Sciences reported fourth-quarter earnings that beat handsomely on both the top and bottom line. The company saw earnings of $0.55 per share versus an estimated $0.50, a 10% increase from the year-ago quarter. Q4 revenue was 20% higher on a year-over-year basis at $3.12 billion versus an estimated $2.85 billion.  (more)

Please share this article